Nicholas Lydon, Director at Blueprint Medicines Corp (BPMC), sold 26,034 shares at $80.29 ($2.1M) on 2020-06-22, disclosed to the SEC on 2020-06-23.
Open-market sale of $2.1M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.29 | 13,017 | $1.0M | 50.0% |
| 2 | $80.29 | 13,017 | $1.0M | 50.0% |
| Total | $80.29 avg | 26,034 | $2.1M | 100% |
| Filing → |
| BPMC | SELL | 2020-07-08 | $4.1M | — | Filing → |
| BPMC | SELL | 2020-07-06 | $661K | — | Filing → |
| BPMC | SELL | 2020-06-25 | $32K | — | Filing → |